These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12843997)

  • 1. [Anti-IgE and future treatments for respiratory allergies].
    Tunon-De-Lara JM; Raherison C; Berger P
    Rev Pneumol Clin; 2003 Apr; 59(2 Pt 1):114-20. PubMed ID: 12843997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-IgE monoclonal antibody: a new approach to the treatment of allergic respiratory diseases.
    D'Amato G; Oldani V; Donner CF
    Monaldi Arch Chest Dis; 2003; 59(1):25-9. PubMed ID: 14533279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-IgE antibodies for the treatment of IgE-mediated allergic diseases.
    Chang TW; Wu PC; Hsu CL; Hung AF
    Adv Immunol; 2007; 93():63-119. PubMed ID: 17383539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale for new treatments aimed at IgE immunomodulation.
    Stokes J; Casale TB
    Ann Allergy Asthma Immunol; 2004 Sep; 93(3):212-7; quiz 217-9, 271. PubMed ID: 15478378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
    Holgate ST; Djukanović R; Casale T; Bousquet J
    Clin Exp Allergy; 2005 Apr; 35(4):408-16. PubMed ID: 15836747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with a combination of anti-IgE and specific immunotherapy for allergic rhinitis and asthma.
    Hamelmann E; Rolinck-Werninghaus C; Wahn U; Kopp MV
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():303-13; discussion 313-5. PubMed ID: 20799475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-IgE--a new treatment for allergic diseases].
    Berkun Y; Shalit M
    Harefuah; 2002 Mar; 141(3):260-2, 314. PubMed ID: 11944220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omalizumab and the immune system: an overview of preclinical and clinical data.
    Johansson SG; Haahtela T; O'Byrne PM
    Ann Allergy Asthma Immunol; 2002 Aug; 89(2):132-8. PubMed ID: 12197568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of anti-IgE antibodies.
    Heusser C; Jardieu P
    Curr Opin Immunol; 1997 Dec; 9(6):805-13. PubMed ID: 9492982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgE and immunoglobulin free light chains in allergic disease: new therapeutic opportunities.
    Redegeld FA; Wortel CH
    Curr Opin Investig Drugs; 2008 Nov; 9(11):1185-91. PubMed ID: 18951298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attainments in atop: special aspects of allergy and IgE.
    Milgrom H
    Adv Pediatr; 2002; 49():273-97. PubMed ID: 12214775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-IGE therapy in asthma].
    Mehiri Ben Rhouma N; Béji M; Louzir B; Daghfous J
    Tunis Med; 2002 Oct; 80(10):575-80. PubMed ID: 12632749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-IgE therapy.
    Brownell J; Casale TB
    Immunol Allergy Clin North Am; 2004 Nov; 24(4):551-68, v. PubMed ID: 15474858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathophysiology of the IgE-dependent reaction in respiratory allergy].
    Boniface S; Magnan A
    Rev Pneumol Clin; 2003 Apr; 59(2 Pt 1):77-83. PubMed ID: 12843992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin E: role in asthma and allergic disease: lessons from the clinic.
    Owen CE
    Pharmacol Ther; 2007 Jan; 113(1):121-33. PubMed ID: 17000005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-IgE therapy in persistent allergic asthma].
    Skiepko R; Zietkowski Z; Tomasiak-Łozowska MM; Bodzenta-Łukaszyk A
    Przegl Lek; 2009; 66(3):141-4. PubMed ID: 19689039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and cellular targets of anti-IgE antibodies.
    Inführ D; Crameri R; Lamers R; Achatz G
    Allergy; 2005 Aug; 60(8):977-85. PubMed ID: 15969677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation.
    Holgate S; Casale T; Wenzel S; Bousquet J; Deniz Y; Reisner C
    J Allergy Clin Immunol; 2005 Mar; 115(3):459-65. PubMed ID: 15753888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase in allergen-specific IgE and ex vivo Th2 responses after a single bronchial challenge with house dust mite in allergic asthmatics.
    van de Pol MA; Lutter R; van Ree R; van der Zee JS
    Allergy; 2012 Jan; 67(1):67-73. PubMed ID: 21958117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Allergies: determinants of T2 lymphocyte polarization and desensitization mechanisms].
    Magnan A; Vervloet D
    Rev Mal Respir; 1997 Jun; 14(3):173-81. PubMed ID: 9411594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.